Summary & Overview
CPT 80069: Renal Function Panel
Headline: CPT 80069 — Renal function panel used to evaluate kidney performance
Lead: CPT 80069 describes the renal function panel, a common laboratory service that aggregates biomarkers to assess kidney function. It is widely used across inpatient and outpatient settings to support diagnosis and management of acute and chronic renal conditions. This code is relevant nationally because kidney disease is a frequent driver of laboratory utilization and clinical decision-making.
Key payers: The analysis covers major commercial payers including Aetna, Blue Cross Blue Shield, Cigna Health, and UnitedHealthcare.
What this publication covers: Readers will find a concise explanation of what CPT 80069 represents, the clinical context for its use, and how it relates to other common laboratory panels. The report outlines typical sites of service and the range of diagnoses associated with renal testing. It summarizes payer coverage considerations and common billing modifiers that affect claim processing. Related CPT tests that clinicians and coding professionals commonly encounter alongside the renal function panel are identified to support accurate code selection and claim bundling decisions.
Why it matters: Accurate coding of the renal function panel influences clinical documentation, laboratory workflow, and reimbursement pathways. Understanding the code’s scope and its relationship to other metabolic or renal-specific tests helps health systems, laboratories, and payers align billing practices with clinical intent.
CPT Code Overview
CPT 80069 is the Renal function panel, a laboratory test panel that assesses kidney function through a set of biochemical measurements. The panel is used to evaluate renal performance, monitor disease progression, and guide clinical management related to kidney health.
Service Type: Laboratory
Typical Site of Service: Independent Laboratory (POS 81)
Clinical & Coding Specifications
Clinical Context
A 62-year-old patient with a history of hypertension presents for routine monitoring of kidney function following an episode of acute kidney injury six weeks prior. The clinician orders a 80069 Renal function panel to assess serum creatinine, blood urea nitrogen, electrolytes, and other renal markers. The specimen is collected at an independent laboratory (POS 81). Results are returned to the ordering provider (Family Medicine or Internal Medicine) and reviewed for changes in renal function or proteinuria, informing further clinical evaluation or management.
Coding Specifications
-
Modifiers
-
90Reference (Outside) Laboratory: Used when the specimen is sent to an outside laboratory for testing and the billing indicates the test was performed by another laboratory. -
91Repeat Clinical Diagnostic Laboratory Test: Used when the same laboratory test is repeated on the same day on the same patient to obtain subsequent results for the same analyte. -
Provider Taxonomies
| Taxonomy Code | Specialty |
|---|---|
291U00000X | Clinical Medical Laboratory |
207Q00000X | Family Medicine Physician |
207R00000X | Internal Medicine Physician |
-
Notes
-
The listed taxonomies represent the laboratory performing testing and the common ordering clinical specialties. Billing and modifier use depend on who performs the test and whether it is repeated.
Related Diagnoses
-
N18.9Chronic kidney disease, unspecified — Relevant as a chronic condition that requires periodic monitoring of renal function with panels such as80069. -
R94.4Abnormal results of kidney function studies — Relevant when prior abnormal laboratory findings prompt repeat or expanded renal testing using80069. -
N17.9Acute kidney failure, unspecified — Relevant in acute renal injury where serial renal function panels are used to monitor recovery or progression. -
N19Unspecified kidney failure — Relevant as a general indication for renal function assessment when the type or acuity of kidney failure is not specified. -
R80.9Proteinuria, unspecified — Relevant because proteinuria is an indicator of renal disease and often prompts measurement of renal function and related laboratory tests such as80069.
Related CPT Codes
| CPT Code | Description | Relationship to 80069 |
|---|---|---|
80053 | Comprehensive metabolic panel | Alternative: broader metabolic panel that includes renal analytes; may be ordered instead of or in addition to 80069 depending on clinical need. |
82565 | Creatinine; blood | Component: single analyte often included within a renal function panel or ordered separately for focused monitoring. |
84520 | Urea nitrogen; quantitative | Component: measures BUN, commonly part of renal assessment and included in 80069. |
84132 | Potassium; serum, plasma or whole blood | Component: electrolyte frequently measured within renal panels; may be billed separately if ordered alone. |
82310 | Calcium; total | Related analyte: calcium measurement may accompany renal testing for metabolic assessment; included in broader panels like 80053 or ordered additionally. |
-
Common usage
-
82565,84520, and84132represent individual tests frequently measured within or alongside a80069Renal function panel.80053is a commonly used alternative when a more comprehensive metabolic evaluation is required.
National Reimbursement Benchmarks
National commercial mean allowed rates are higher for BUCA (average commercial) at $10.35 compared with Medicare at $0.00 for CPT 80069 in the provided input. Aetna and Cigna report the highest commercial means among the listed payers at $12.95 and $11.65 respectively, while UnitedHealth Group reports the lowest mean at $7.41.
Rate dispersion (P75 minus P25) is widest for Cigna (12.00 − 5.00 = 7.00) and Aetna (10.00 − 6.00 = 4.00), indicating greater variability in allowed amounts. UnitedHealth Group shows one of the tightest spreads (8.00 − 4.00 = 4.00) similar to Aetna by this simple range measure, and BUCA and Blue Cross Blue Shield show moderate dispersion. The table and chart below present the full percentile and mean breakdown.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.